Physicians and the pharmaceutical industry.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

• Publication date

  1990-09-01

• Fields of study

  Medicine, Business

• Identifiers
  DOI 10.7326/0003-4819-113-5-407PMID 11654903PMCID PMC1488237
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Pizza Parade

  1990cited by this paper
• Doctors, drug companies and gifts.

  1989cited by this paper

• Promotion of Medicines and Patient Health

  2020cites this paper
• Attitudes and behaviours of physicians towards the relationship with the pharmaceutical industry in Saudi Arabia.

  2020cites this paper
• Drug Company Sponsorship of Clinical Conferences Two physicians assert that pharmaceutical companies ' sponsorship of clinical conferences for residents and physicians represent a conflict of interest

  2018cites this paper
• Reading between the lines: questionable medical and journalistic ethics in Israeli newspaper coverage of medications

  2017cites this paper
• La croissance technologique et la privatisation passive des systèmes publics de santé : le cas du Québec

  2017influential citation
• Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians’ attitudes and prescribing habits: a systematic review

  2017cites this paper
• INFLUENTIAL FACTORS ON PRESCRIPTION; A CROSS SECTIONAL STUDY FROM BANGLADESH: FOCUS ON PHARMACEUTICAL MARKETING

  2016cites this paper
• Health Care Adherence and Personalized Medicine

  2016cites this paper
• Pricing and Promotional Decisions of a Drug Manufacturer with the Presence of a Price-Volume Agreement

  2016cites this paper
• Operational perspectives on extended producer responsibility for durable and consumable products

  2015cites this paper
• Financial Conflicts of Interest in Medicine

  2014cites this paper
• Prescribing Promotional Targeted Drugs: The Explanatory Phenomena (Part II: A Qualitative Study)(การสั่งจ่ายยาที่มีการมุ่งส่งเสริมการขาย: การอธิบายปรากฎการณ์ที่เกิดขึ้น(ตอนที่ 2 – การศึกษาวิจัยเชิงคุณภาพ))

  2014cites this paper
• Les déterminants de la prescription médicamenteuse en médecine générale

  2014cites this paper
• Closing the Marketing Strategy-Tactics Gap: An Institutional Theory Analysis of Pharmaceutical Value Chain

  2014cites this paper
• Les déterminants de la prescription médicamenteuse en médecine générale

  2014cites this paper
• Pharmaceutical Drug Promotion in Pakistan: Issues in Ethical and Non-Ethical Practices

  2014cites this paper
• Impact of Pay for Performance on Prescribing of Long-Acting Reversible Contraception in Primary Care: An Interrupted Time Series Study

  2014cites this paper
• Optometry Students' Exposure to and Perspectives on Pharmaceutical Industry Gifts and Interactions

  2014cites this paper
• A Review of Canadian Medical School Conflict of Interest Policies

  2013influential citation
• A Review Article on Prescription Behavior of Doctors, Influenced By The Medical Representative In Rajasthan, India

  2013cites this paper
• Physicians’ perceptions of medical representative visits in Yemen: a qualitative study

  2013cites this paper
• Trends in medical management of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

  2013cites this paper
• Physician Payment Disclosure Under Health Care Reform: Will the Sun Shine?

  2013cites this paper
• Breaking Up is Hard to Do: Lessons Learned from a Pharma-Free Practice Transformation

  2013cites this paper
• A pilot study evaluating alternative approaches of academic detailing in rural family practice clinics

  2012cites this paper
• Challenges of continuing medical education in Saudi Arabia's hospitals

  2012influential citation
• Huddle Gets It Right, Most Docs Don't

  2010cites this paper
• Pharmaceutical industry support and residency education: a survey of internal medicine program directors.

  2010cites this paper
• A COMPARATIVE STUDY OF BRANDED VERSUS BRANDED GENERICS IN INDIA

  2010cites this paper
• Contact with Pharmaceutical Representatives: Where Does Prudence Lead?

  2010cites this paper
• The AAMC Exhibits the Behavior it Condemns

  2010cites this paper
• Corporate-physician relationships: A need for education

  2009cites this paper
• The Decline of Pharmaceutical Psychiatry and the Increasing Role of Psychological Medicine

  2009cites this paper
• Marketing Off-Label Uses to Physicians: FDA's Draft (Mis)Guidance

  2008cites this paper
• The need for an Institute of Continuing Health Education

  2008cites this paper
• Competing interests in development of clinical practice guidelines for diabetes management: Report from a multidisciplinary workshop

  2008cites this paper
• Pharmasponsoring in der ä rztlichen Fort-und Weiterbildung Pharmaceutical Industry Sponsored Medical Education

  2008cites this paper
• Opioid therapy and prescription drug diversion.

  2008cites this paper
• implications for countervailing powers theory News media coverage of direct-to-consumer pharmaceutical advertising

  2007cites this paper
• La formation médicale continue est-elle un outil de promotion pharmaceutique?: OUI

  2007cites this paper
• Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia

  2006cites this paper
• Regulating the Market in Human Research Participants

  2006cites this paper
• Can Health Journalists Bridge the State-of-the-Science Gap in Mammography Guidelines?

  2006cites this paper
• Physicians and the pharmaceutical industry –‘dualities of interest’

  2006cites this paper
• Physicians and the pharmaceutical industry

  2006cites this paper
• PAIN MANAGEMENT

  2006cites this paper
• The Connection Between Academia and Industry

  2005cites this paper
• The Contract Research Organization and the Commercialization of Scientific Research

  2005cites this paper
• Introduction-Ironies of success: A new history of the American health care "system"

  2005cites this paper
• Will Lower Drug Prices Jeopardize Drug Research? A Policy Fact Sheet

  2004cites this paper
• Not For Sale, Not Even For Rent: Just Say No. Thoughts About the American College of Rheumatology Adopting a Code of Ethics

  2004cites this paper
• What Residents Don't Know about Physician–Pharmaceutical Industry Interactions

  2004influential citation
• Industry and Academic Medicine: A Dangerous Liaison?

  2004cites this paper
• Didactic Teaching Conferences for IM Residents: Who Attends, and Is Attendance Related to Medical Certifying Examination Scores?

  2003cites this paper
• Physician and Practice Characteristics Associated with the Early Utilization of New Prescription Drugs

  2003cites this paper
• Conflict of interest and the credibility of medical journals

  2003cites this paper
• The Ethics of Pharmaceutical Industry Gift-Giving: The Role of a Professional Association

  2003cites this paper
• Continuing medical education: ethical collaboration between sponsor and industry.

  2003cites this paper
• Newspaper Coverage of the 1988 Aspirin and 2002 Hormone Therapy Randomized Clinical Trials

  2003cites this paper
• The corporate presence at oncology meetings.

  2002cites this paper
• DESIGN AND REPORTING MODIFICATIONS IN INDUSTRY-SPONSORED COMPARATIVE PSYCHOPHARMACOLOGY TRIALS

  2002cites this paper
• Policy options for cost containment of pharmaceuticals

  2002cites this paper
• Profits and professionalism.

  2002cites this paper
• Scope of the problem

  2002cites this paper
• Price and productivity measurement in a pharmaceutical sector sub-market : the real cost of treating hypertension

  2001cites this paper
• Separating continuing medical education from pharmaceutical marketing.

  2001cites this paper
• Avoiding Exploitation in Clinical Research

  2000cites this paper
• Health and Economic Benefits of Increased (cid:98) -Blocker Use Following Myocardial Infarction

  2000cites this paper
• Pharmaceutical advertising revenue and physician organizations: how much is too much?

  1999cites this paper
• Regulating manufacturer‐affiliated communication in the information age

  1999cites this paper
• TALKING ABOUT CLINICAL PRACTICE GUIDELINES: HOW MUCH SHOULD PATIENTS BE TOLD?

  1999cites this paper
• Free gift

  1998cites this paper
• [Incentives for doctors from the pharmaceutical industry: ethical problems, limits, and alternatives].

  1997cites this paper
• The introduction of new drugs into anaesthetic practice: a perspective in pharmaceutical development and regulation

  1995cites this paper
• Separating the wheat from the chaff

  1994cites this paper
• Reflections on a month in the life of the Ontario Drug Benefit Plan.

  1994cites this paper
• Professional Organizations and Healthcare Industry Support: Ethical Conflict?

  1994cites this paper
• Medical Ethics: An Annotated Bibliography

  1994cites this paper
• The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities

  1993cites this paper
• Interactions between physicians and the pharmaceutical industry: what does the literature say?

  1993cites this paper
• Letters: Prince Dracula, Rabies, and the Vampire Legend

  1993cites this paper
• Role of Industry Representatives in Providing Assistance to Certified Diabetes Educators

  1992cites this paper
• Ethical relationships between drug companies and the medical profession.

  1992cites this paper
• Truth or Consequences

  1992cites this paper
• Observations on ethical problems and terminal care.

  1992cites this paper
• Drug utilization in general practice: prescribing habits of National Formulary drugs by GPs of Emilia Romagna (Italy) in 1988 and 1989

  1992cites this paper
• Conflict of interest and informed consent in industry-sponsored clinical trials.

  1991cites this paper